Mr. Hugh MacNaught reports

VENTRIPOINT AND OLLIE HINKLE HEART FOUNDATION PARTNER TO EXPAND ACCESS TO AI-POWERED HEART IMAGING FOR CHILDREN LIVING WITH HEART DISEASE

Ventripoint Diagnostics Ltd. has entered a strategic collaboration with Ollie Hinkle Heart Foundation to expand access to artificial-intelligence-powered cardiac imaging and clinical decision support technology for children and adults living with congenital and childhood-onset heart disease.

The collaboration combines Ventripoint's AI-powered VMS+ cardiac imaging platform with OHHF's take heart collective impact model, which brings together health care providers, innovators, researchers, patients, families and social partners -- including Jovie's Joy and Ella's Umbrella -- to accelerate innovation and improve outcomes for children and families impacted by heart disease.

As part of the collaboration, OHHF will initially provide financial support enabling the placement of two VMS+ systems within its health care partner network and further opportunities for education, advocacy, research, technology adoption and community engagement initiatives.

Ventripoint's VMS+ platform uses artificial intelligence and advanced cardiac modelling to provide clinicians with highly accurate measurements of heart structure and function from a standard echocardiogram. By delivering sophisticated cardiac insights in a more accessible and efficient way, VMS+ enhances clinical decision making, supports continuing patient monitoring and expands access to advanced cardiac assessment across a wide range of heart conditions.

"Improving outcomes for people living with heart disease begins with access to accurate, timely and affordable cardiac imaging," said Joe Hostetter, director of the congenital heart disease program at Ventripoint Diagnostics. "Ollie Hinkle Heart Foundation has become a respected leader in bringing together families, clinicians, health care systems and innovators to solve complex challenges facing children and families impacted by heart disease. Together, we have an opportunity to expand access to advanced imaging solutions that help clinicians make more informed decisions and improve care throughout a patient's journey."

The partnership is rooted not only in technology but in the lived experiences of families who understand first-hand the importance of better information, safer testing options and more informed treatment decisions.

"As a mother of a child living with dilated cardiomyopathy, I know first-hand the impossible decisions families can face when trying to get answers about their child's heart," said Katie Nesselbush, founder of Jovie's Joy and social partner of Ollie Hinkle Heart Foundation .

"Technologies like Ventripoint give physicians more information to guide care while reducing barriers and risk for families. Every parent wants confidence that they're making the best possible decisions for their child, and every child deserves access to the most advanced tools available."

"When our son Ollie passed away at just 13 months old, we learned first-hand how quickly a child's condition can change," said Mark Hinkle, co-founder of Ollie Hinkle Heart Foundation.

"We can't change Ollie's story, and we can't bring Ella back. But we can honour them by ensuring more children have access to the technology, information and treatment options they never had. That's the future we're building through the take heart collective impact model."

Together, Ventripoint, Ollie Hinkle Heart Foundation, Jovie's Joy and Ella's Umbrella are demonstrating how lived experience and innovation can work hand in hand to expand access to advanced cardiac imaging and innovative technologies for children living with heart disease.

About Ventripoint Diagnostics Ltd.

Ventripoint has become an industry leader in the application of artificial intelligence to echocardiography. Ventripoint's VMS products are powered by its proprietary knowledge-based reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI. This affordable, gold standard alternative allows cardiologists greater confidence in the management of their patients. Providing better care to patients serves as a springboard and basic standard for all of Ventripoint's products that guide future developments. In addition, VMS+ is versatile and can be used with all ultrasound systems from any vendor supported by regulatory market approvals in the United States, Europe and Canada.

We seek Safe Harbor.